FDA issues guidance on disclosing amount of live microbial ingredients in supplements
FDA on Thursday recognized the benefits of disclosing on labels the number of live microbials in dietary supplements—an issue of interest to marketers of probiotics. FDA stopped short of amending its labeling regulations, denying a request filed by the International Probiotics Association (IPA). However, the agency revealed plans to “exercise enforcement discretion” for companies that…